Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Forty Seven Inc (NQ: FTSV )

95.51 USD UNCHANGED
Last Price Updated: 7:49 PM EDT, Apr 6, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 95.51
Bid (Size) 95.46 (219)
Ask (Size) 95.50 (9)
Prev. Close 95.51
Today's Range 95.51 - 95.51
52wk Range 36.18 - 95.51
Shares Outstanding 29,960,103
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Gilead Completes Acquisition of Forty Seven, Inc.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction for Toro Merger Sub, Inc., a wholly owned subsidiary of Gilead (“Purchaser”), to acquire... 
From Business Wire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds MEET, CBB, DLPH, and FTSV Shareholders About Its Ongoing Investigations
From GlobeNewswire News Releases

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+142.78%
+142.78%

More News

Read More
SHAREHOLDER INVESTIGATION: Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - GCAP, FTSV, MINI
From ACCESSWIRE
Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies – FTSV, MINI, MEET, WLTW
From GlobeNewswire News Releases
Lifshitz Law Firm, P.C. Announces Investigation of Forty Seven, Inc., Hexcel Corporation, Legg Mason, Inc., and Mobile Mini, Inc.
From GlobeNewswire News Releases
Forty Seven, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
From GlobeNewswire News Releases
Gilead Analyst Sees Over 50% Chance Of Success For Remdesivir In Mild-To-Moderate COVID-19
Tags Benzinga coronavirus General
From Benzinga
There's More to Gilead Sciences' Remdesivir Data Than Meets the Eye
Tags FTSV Market News GILD
From Motley Fool
Gilead Sciences’ Remdesivir Data Release Brings Much Needed Relief for Patients and Investors
Tags Market News FTSV ABBV
From Motley Fool
Why Forty Seven Stock Skyrocketed 64.5% in March
Tags FTSV Market News GILD
From Motley Fool
Should You Buy Gilead Sciences Stock Right Now?
Tags GILD FTSV Market News
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.